| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744934 | Clinical Microbiology and Infection | 2018 | 7 Pages |
Abstract
High effectiveness of RotaTeq as the sole rotavirus vaccine in a universal immunization programme was demonstrated in a high-income country. Although partial vaccination conferred protection, completing the vaccine series is warranted to maximize the benefit.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
K. Muhsen, E. Anis, U. Rubinstein, E. Kassem, S. Goren, L.M. Shulman, M. Ephros, D. Cohen,